Mark Anthony Tyndall

CIK 1944622 · EVP & CLO and Corp Sec · last filed 2026-02-26

Mark Anthony Tyndall is an EVP & CLO and Corp Sec who has filed 10 SEC Form 4 insider transactions across 1 company since 2022.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

10

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Keenova Therapeutics plc (MNK) Delisted EVP & Chief Legal Offi & Secre 63,802 $0.34 $21.7K $0 4 2023-08-18

Recent Filings

10 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-02-26 Grant (A) $0
2026-01-05 Mixed +4,469 $0
2025-08-04 Grant (A) $0
2025-01-02 Mixed +3,698 $0
2024-02-06 Grant (A) $0
2023-11-16 Disp (D) −63,802 $0
2023-08-18 Keenova Therapeutics plc (MNK) Delisted Tax (F) −11,289 -$7.8K EDGAR
2023-07-05 Keenova Therapeutics plc (MNK) Delisted Disp (D) $0 EDGAR
2023-04-05 Keenova Therapeutics plc (MNK) Delisted Grant (A) $0 EDGAR
2022-12-22 Keenova Therapeutics plc (MNK) Delisted Grant (A) +75,091 $0 EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.